Respiro Diagnostics raises $1.3M pre seed
Announced 8 July 2026
◆ The Round
Respiro Diagnostics raised $1.3M in pre seed funding, announced on 8 July 2026, led by Zinc Venture Capital, SFC Capital, with participation from Amadeus Capital Partners, Conception X Angel Syndicate, KQ Labs, Francis Crick Institute, Innovate UK. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
◆ About Respiro Diagnostics
UK-based startup developing breath-based diagnostics for lung diseases using non-invasive liquid biopsy technology. Respiro Diagnostics is based in United Kingdom and currently at pre seed stage, operating in Digital Health.
◆ Investors
LeadZinc Venture Capital, SFC Capital
ParticipationAmadeus Capital Partners, Conception X Angel Syndicate, KQ Labs, Francis Crick Institute, Innovate UK
◆ Market context
This funding event is a citable node in Fusion42's market graph: it links Respiro Diagnostics's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.
◆ Explore the market
◆ FAQ
How much did Respiro Diagnostics raise?
Respiro Diagnostics raised $1.3M in its pre-seed round, announced 2026-07-08.
Who invested in Respiro Diagnostics's pre-seed round?
The round was led by Zinc Venture Capital and SFC Capital, with participation from Amadeus Capital Partners, Conception X Angel Syndicate, KQ Labs, Francis Crick Institute and Innovate UK.
What does Respiro Diagnostics do?
UK-based startup developing breath-based diagnostics for lung diseases using non-invasive liquid biopsy technology.
Verified 8 July 2026 · Sources: public filings